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Abstract  30 
Heparan sulphate (HS) is a cell surface and extracellular matrix carbohydrate extensively 31 
modified by differential sulphation. HS interacts physically with canonical fibroblast growth 32 
factor (FGF) proteins that signal through the extracellular signal regulated kinase 33 
 2 
 
(ERK)/mitogen activated kinase (MAPK) pathway. At the embryonic mouse telencephalic 34 
midline FGF/ERK signalling drives astroglial precursor somal translocation from the 35 
ventricular zone of the cortico-septal boundary (CSB) to the induseum griseum (IG) 36 
producing a focus of Slit2-expressing astroglial guidepost cells essential for inter-hemispheric 37 
corpus callosum (CC) axon navigation. Here we investigate the cell and molecular function 38 
of a specific form of HS sulphation, 2-O HS sulphation catalysed by the enzyme Hs2st, in 39 
midline astroglial development and in regulating FGF protein levels and interaction with HS. 40 
Hs2st-/- embryos of either sex exhibit a grossly enlarged IG due to precocious astroglial 41 
translocation and conditional Hs2st mutagenesis and ex vivo culture experiments show that 42 
Hs2st is not required cell autonomously by CC axons or by the IG astroglial cell lineage but 43 
rather acts non cell autonomously to suppress the transmission of translocation signals to 44 
astroglial precursors. Rescue of the Hs2st-/- astroglial translocation phenotype by 45 
pharmacologically inhibiting FGF signalling shows the normal role of Hs2st is to suppress 46 
FGF-mediated astroglial translocation. We demonstrate a selective action of Hs2st on FGF 47 
protein by showing that Hs2st (but not Hs6st1) normally suppresses the levels of Fgf17 48 
protein in the CSB region in vivo and use a biochemical assay to show Hs2st (but not Hs6st1) 49 
facilitates physical interaction between Fgf17 protein and HS. 50 
 51 
Significance statement.  52 
We report a novel non cell autonomous mechanism regulating cell signalling in developing 53 
brain. Using the developing mouse telencephalic midline as an exemplar we show that the 54 
specific sulphation modification of the cell surface and extracellular carbohydrate heparan 55 
sulphate (HS) performed by Hs2st suppresses the supply of translocation signals to astroglial 56 
precursors by a non cell autonomous mechanism. We further show that Hs2st modification 57 
selectively facilitates physical interaction between Fgf17 and HS and supresses Fgf17 protein 58 
levels in vivo, strongly suggesting that Hs2st acts selectively on Fgf17 signalling.  HS 59 
interacts with many signalling proteins potentially encoding numerous selective interactions 60 
important in development and disease so this class of mechanism may apply more broadly to 61 
other biological systems.  62 
 63 
Introduction 64 
The corpus callosum (CC) axon tract connects the cerebral hemispheres through the 65 
cortico-septal boundary (CSB) in mice and humans and CC malformation is associated with 66 
cognitive and neurological conditions in humans (Donahoo and Richards, 2009). Precisely 67 
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controlled radial glial cell (RGC) somal translocation from the ventricular zone (VZ) of the 68 
CSB to its pial surface generates midline zipper (MZ) and induium griseum (IG) astroglial 69 
populations required for cerebral hemisphere fusion and subsequent CC axon navigation 70 
(Clegg et al., 2014; Gobius et al., 2016; Inatani et al., 2003; Moldrich et al., 2010; Shu and 71 
Richards, 2001; Shu et al., 2003; Smith et al., 2006). The movement of RGC astroglial 72 
precursors from the glial wedge (GW) to the IG (GW→IG translocation) forms an astroglial 73 
guidepost population that secretes Slit2 to guide CC axons across the telencephalic midline.  74 
Fibroblast growth factors (FGFs) are an evolutionarily ancient family comprising 23 75 
genes in mice and humans of which 15 (Fgf1-10,16-18,20,22 in mice) encode ‘canonical’ 76 
FGFs that function as paracrine signalling molecules and bind promiscuously to cell surface 77 
FGF receptors (FGFRs encoded by Fgfr1-4 in mice) to elicit an extracellular signal regulated 78 
kinase (ERK)/mitogen activated kinase (MAPK) response via activating phosphorylation of 79 
ERK→phospo-ERK (pERK). Canonical FGFs are further subdivided into five subfamilies 80 
based on phylogeny and ‘Fgf8’ subfamily members Fgf8 and Fgf17 are transcribed in the 81 
developing CSB in close spatiotemporal proximity posing the question of how they are 82 
coordinated (Guillemot and Zimmer, 2011; Ornitz and Itoh, 2015). Under normal conditions 83 
GW→IG translocation is primarily attributed to Fgf8 and needs to be tightly regulated to 84 
ensure correct numbers of RGCs leave the GW and reach the IG. Deviation above (or below) 85 
normal FGF/ERK signalling levels induces too many (or too few) RGCs to translocate with 86 
consequent disruption to CC development (Clegg et al., 2014; Gobius et al., 2016; Smith et 87 
al., 2006; Wang et al., 2012). While Fgf17 plays a role in patterning the developing 88 
telencephalon its importance for CC development is less clear and no CC phenotype has been 89 
reported in Fgf17-/- embryos (Cholfin and Rubenstein, 2007, 2008). Because Fgf8 and Fgf17 90 
are the principal Fgf’s transcribed in vicinity of the GW and both activate ERK, mechanisms 91 
must exist to keep the total amount of Fgf protein (Fgf8 protein + Fgf17 protein) at the 92 
correct level to generate the correct levels of ERK activation for astroglial precursor RGCs to 93 
translocate in appropriate numbers.  94 
 Heparan sulphate (HS), the carbohydrate component of cell surface and extracellular 95 
matrix (ECM) heparan sulphate proteoglycans, is a negatively charged sulphated 96 
polysaccharide that binds canonical FGFs in the ECM to regulate their movement and half-97 
life and also functions as an obligate FGF co-receptor in FGF:FGFR:HS ternary signalling 98 
complexes on the cell surface (Balasubramanian and Zhang, 2016; Guillemot and Zimmer, 99 
2011).  HS biosynthesis is in two stages, Ext enzymes polymerise uronic acid – glucosamine 100 
disaccharides making linear [uronic acid – glucosamine]n HS polymers which are then 101 
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modified by the enzymatic addition (by heparan sulphate sulphotransferases, HSTs) or 102 
removal (by heparan sulphate sulphatases, Sulfs) of sulphate groups at specific positions on 103 
the disaccharide residues. There are four classes of HST enzymes (Hs2st, Hs3st, Hs6st, and 104 
Ndst) each adding sulphate to a specific position, for example Hs2st only adds sulphate to the 105 
carbon atom in position 2 of uronic acid generating 2-O HS sulphation. While work in a 106 
variety of systems shows that HS itself can play roles both in the transmission of FGF signals 107 
through the ECM (non cell autonomous role) and the cellular response to FGF (cell 108 
autonomous role) the potential for specific forms of HS sulphation to selectively regulate 109 
FGFs by regulating the physical interaction between HS and FGF proteins is much less well 110 
understood (Allen et al., 2001; Allen and Rapraeger, 2003; Balasubramanian and Zhang, 111 
2016; Belenkaya et al., 2004; Chan et al., 2015; Chan et al., 2017; Christian, 2012; Guillemot 112 
and Zimmer, 2011; Kinnunen et al., 2005; Loo et al., 2001; Loo and Salmivirta, 2002; 113 
Makarenkova et al., 2009; Qu et al., 2011; Qu et al., 2012; Ramsbottom et al., 2014; Toyoda 114 
et al., 2011; Yan and Lin, 2009; Yu et al., 2009; Zhang et al., 2012a).  115 
 The heparan sulphate code hypothesis states that different forms of HS sulphation can 116 
encode specific instructions (Kreuger et al., 2006; Turnbull et al., 2001). In this study we 117 
discover that 2-O HS sulphation catalysed by Hs2st functions non cell autonomously at the 118 
developing telencephalic midline to supress FGF/ERK signalling that drives the somal 119 
translocation of astroglial precursors required for normal CC development and present 120 
evidence that Hs2st plays a selective role by modulating the physical interaction between 121 
Fgf17 protein and HS and selectively supressing Fgf17 protein levels at the CSB. 122 
 123 
Materials and Methods 124 
Animals: All mice were bred in-house in line with Home Office UK legislation and licences 125 
approved by the University of Edinburgh Ethical Review Committees and Home Office. 126 
Embryos analysed in this study were of either sex. Animal husbandry was in accordance with 127 
UK Animals (Scientific Procedures) Act 1986 regulations. The Hs2st LacZ (Hs2st-) null 128 
allele comprised a LacZ gene trap vector integrated into the Hs2st locus, the Hs6st1 129 
LacZiresPLAP (Hs6st1-) null allele comprised a LacZiresPLAP gene trap vector integrated in 130 
the Hs6st1 locus, both were genotyped by PCR as previously described (Bullock et al., 1998; 131 
Conway et al., 2011; Pratt et al., 2006). For some ex vivo experiments Hs2st-/+ mice were 132 
crossed with mice carrying the TP6.3 Tau (τ) -GFP fusion transgene to generate Hs2st-/- and 133 
Hs2st+/+ embryos with τGFP+ axons (Pratt et al., 2000). For conditional mutagenesis floxed 134 
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Ext1 (Ext1fl) or Hs2st (Hs2stfl) alleles were combined with either Zic4Cre  (septal deletion) or 135 
Emx1CreER (cortical deletion) driver alleles (Inatani et al., 2003; Kessaris et al., 2006; Rubin et 136 
al., 2010; Stanford et al.). CreER activity was induced at E9.5 by administering tamoxifen 137 
(dissolved in corn oil using a sonicator) to pregnant dams by intraperitoneal (IP) injection 138 
(120mg/kg dose). Lineages of cells in which Cre was active were visualised using a 139 
Rosa26R-floxed-stop-EGFP reporter allele (Sousa et al., 2009). 140 
Ex vivo assays: Ex vivo culture experiments were performed essentially as described 141 
previously (Niquille et al., 2009) Explants were cultured on nucleopore polycarbonate 142 
membranes (Whatman) floating on 1 ml ‘Neurobasal media’ (Neurobasal medium (Life 143 
Technologies) supplemented with L-glutamine, glucose and penicillin/streptomycin) at 37oC 144 
with 5% CO2 in a humidified incubator. Brains were dissected from embryos in oxygenated 145 
Earle’s balanced salt solution (Life Technologies), embedded in low melting point agarose, 146 
sliced using a vibratome (Leica VTS-1000), and transferred to Modified Eagle medium 147 
(MEM, Life Technologies) with 5% foetal bovine serum for 1 hour. For CC axon navigation 148 
assays 400μm thick E17.5 coronal slices incorporating the CC axon tract were prepared and 149 
frontal cortex explants from τ-GFP+ slices were transplanted into the equivalent region in τ-150 
GFP- slices prior to culturing in Neurobasal media for 72 hours, fixation in 4% 151 
paraformaldehyde (PFA), and GFP immunofluorescence. For glial translocation experiments 152 
10 mg/ml BrdU dissolved in PBS was injected IP into pregnant dams with E14.5 litters which 153 
were sacrificed 1 hour later and 350μm coronal slices incorporating the CSB prepared for 154 
culture. In Fgf17 bead experiments Affi-gel blue gel (Bio-rad) beads pre-soaked in 100μg/ml 155 
recombinant Fgf17 protein (R&D systems) or 5mg/ml BSA (Sigma) overnight at 4oC were 156 
implanted into the slice, one Fgf17 and one BSA bead on either side of the midline just below 157 
the GW, and the MEM replaced with Neurobasal media. For the FGFi culture, MEM media 158 
was replaced with Neurobasal media containing either 25μM SU5402, 0.1% DMSO (FGF 159 
inhibitor (FGFi) treated) or 0.1% DMSO (control). Slices were cultured for 2 or 48 hours, 160 
fixed in 4% PFA, and 10μm frozen sections prepared for immuno-detection or in situ 161 
hybridisation. Glial migration out of the VZ towards the pial surface was quantified from 162 
BrdU/Sox9 immunofluorescence micrographs by demarcating the basal edge of the VZ 163 
(easily identified by Sox9 staining) with a line and counting the number of Sox9+;BrdU+ cells 164 
which had crossed this line. This allowed us to count glial (Sox9+) cells that had incorporated 165 
BrdU (BrdU+) when they were in the VZ before the start of the culture and subsequently 166 
exited the VZ and migrated towards the midline over the 2 day culture period when the 167 
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cultures were exposed to experimental substances (SU5402, DMSO, Fgf17 protein, or BSA). 168 
4 or 6 sections were quantified per slice moving rostrally from the most caudal section in 169 
which the GW could be identified on both sides of the section. 170 
Immunodetection: Embryonic mouse brains were removed and fixed in 4% PFA in PBS 171 
overnight at 4oC, cryoprotected in 30% sucrose in PBS, embedded in OCT, and 10μm 172 
coronal frozen sections cut using a cryostat (Leica). Immunohistochemistry was performed as 173 
described previously (Clegg et al., 2014). Primary antibodies: goat anti-GFP (diluted 1/250, 174 
Abcam); rabbit anti-Sox9 (1/500, Cell Signalling Technologies); rat anti-L1 (1/200, 175 
Millipore); rabbit anti-GFAP (1/200 Dako); rabbit anti-Hs2st (1/50, Abcam ab103120); rabbit 176 
anti-Fgf17 (1/1000, Abcam ab187982); and rabbit anti-pErk1/2 (1/200, Cell signalling). 177 
Secondary antibodies; donkey anti-goat Alexa Fluor 488; donkey anti-rabbit Alexa Fluor 178 
568; and goat anti-rat 568 (all used at a dilution of 1/200 and from Invitrogen). Fluorescently 179 
labelled sections were counterstained with DAPI (Invitrogen). For Hs2st and pErk1/2 180 
antibody staining goat anti-rabbit biotin secondary antibody (1/200, Vector Laboratories) was 181 
used and staining was visualised using a standard avidin-biotin diaminobenzidine (DAB) 182 
staining procedure. The  Fgf17 immunofluorescence was performed using exactly the same 183 
protocol as previously described for Fgf8 except that the Fgf8 antibody was replaced with the 184 
Fgf17 antibody (Clegg et al., 2014; Toyoda et al., 2011). Briefly, slides were first washed in 185 
acetone for permeabilisation, Rabbit Fgf17 antibody applied, and the TSA plus Fluorescence 186 
System kit (Perkin Elmer) used for fluorescence detection. 187 
In situ Hybridisation: In situ hybridisation was carried out on 10μm frozen sections as 188 
previously described (Wallace and Raff, 1999) using digoxigenin-labelled riboprobes for 189 
Slit2 and Fgf17 (Erskine et al., 2000; Xu et al., 1999). 190 
Imaging: Fluorescent labelled sections were imaged using either a Leica AF6000 191 
epifluorescence microscope coupled to a Leica DFC360 digital camera or a Nikon Ti: E 192 
Inverted confocal microscope. DAB stained and in situ hybridised sections were imaged 193 
using a Leica DLMB microscope coupled to a Leica DFC480 colour digital camera.  194 
Fgf17 protein quantification: Fgf17 fluorescence was quantified from E14.5 195 
Hs2st+/+;Hs6st1+/+, Hs2st-/- and Hs6st1-/- coronal sections that had been processed for Fgf17 196 
immunofluorescence in parallel and imaged under identical conditions in parallel using the 197 
same method as previously described for Fgf8 protein quantification (Chan et al., 2017). For 198 
each section IMAGE J was used to measure mean fluorescence intensity in a 100 x 150 μm 199 
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box drawn at the CSB encompassing the Fgf17 expression domain. For each embryo 200 
quantification was performed for three sections along the rostro-caudal axis and averaged. 201 
IG Sox9+ cell quantification: Quantification of Sox9 immunofluorescent positive cells 202 
(Sox9+ cells) in the IG region of E18.5 Hs2stfl/fl;Zic4Cre, Hs2st+/+;Zic4Cre Hs2stfl/fl;Emx1CreER, 203 
and Hs2st+/+;Emx1CreER embryos were performed as previously described (Clegg et al., 204 
2014). A counting box measuring 200μm x 200μm was placed on images of coronal sections 205 
at the midline with the top edge at the dorsal extent of Sox9+ cells at the IG and the numbers 206 
of Sox9+ cells in the box counted. For each embryo quantification was performed for three 207 
sections along the rostro-caudal axis and averaged. 208 
Western Blotting: Western blotting was performed as previously described (Clegg et al., 209 
2014), primary antibodies: rabbit anti-Hs2st (1/500, Abcam ab103120) and mouse anti-β-210 
actin (1/5000, Abcam). Secondary antibodies: goat anti-mouse Alexa Fluor 680 (Invitrogen) 211 
and goat anti-rabbit 800 (Li-Cor). 212 
Ligand and Carbohydrate Engagement (LACE) Assay: LACE assay was performed as 213 
previously described (Allen et al., 2001; Allen and Rapraeger, 2003; Chan et al., 2015). 214 
Briefly, frozen sections were incubated in 0.05% NABH4/PBS for 15 min. After several 215 
washes in PBS, sections were incubated in 0.1M glycine at 4oC overnight. Some sections 216 
were incubated with Heparitinase I (Seikagaku) before proceeding. All Fgf and Fgfr-Fc 217 
proteins were purchased from R&D Systems. Sections were then treated with 1% BSA/TBS 218 
solution for 10 min before incubation with 3 μM recombinant mouse Fgf17 and 9 μM 219 
recombinant human Fgfr1a(IIIc)-Fc or 30nM recombinant mouse Fgf8b and 100nM 220 
recombinant human Fgfr3 (IIIc)-Fc at 4oC overnight. Fgf17 or Fgf8 were omitted from some 221 
assays. Fluorescent LACE signal was generated by incubation with 1/200 anti-human IgG 222 
(Fc-specific) Cy3 (Sigma) in 1% BSA/TBS. Hs2st+/+;Hs6st1+/+, Hs2st-/- and Hs6st1-/- 223 
material that had been processed for each LACE assay condition in parallel were imaged 224 
under identical conditions in parallel. For each section IMAGE J was used to measure mean 225 
fluorescence intensity in a 100 x 150 μm box drawn encompassing the CSB. Background 226 
signal was quantified from control LACE experiments from which the FGF ligand was 227 
omitted and these values used for background subtraction. For each embryo quantification 228 
was performed for three sections along the rostro-caudal axis and averaged. 229 
Data analysis and statistics: Results are expressed as mean ±SEM. The statistical test and 230 
sample size (n) for each experiment are specified in the figure legends. Statistical comparison 231 
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between 2 groups was performed with a t-test. Statistical comparison between > 2 groups was 232 
performed with ANOVA followed by post-hoc t-test. p < 0.05 was considered significant. 233 
Results 234 
Hs2st protein is widely expressed in the developing cerebral cortex and at the 235 
telencephalic midline.  236 
In order to establish potential sites of action of Hs2st in CC development we first 237 
examined the distribution of cells expressing Hs2st protein and contributing to developing 238 
CC structures using Hs2st immunohistochemistry at E14.5 (Fig 1 A-D) and E18.5 (Fig 1 E-239 
M) spanning the period of CC axon tract development.  Macroscopically, Hs2st protein 240 
distribution closely resembles the Hs2st-LacZ reporter staining previously reported with 241 
widespread Hs2st expression in the developing cerebral cortex and at the CSB at both E14.5 242 
and E18.5 (Fig 1A,E, boxed areas indicate regions shown at higher magnifications in B-D 243 
and F-M) (Conway et al., 2011). Subcellularly the Hs2st signal is punctate consistent with the 244 
expected localisation of Hs2st in the Golgi apparatus (arrows point to Hs2st+ puncta in higher 245 
magnification insets in Fig 1B,F,P). At E14.5 there was a high density of Hs2st+ puncta at the 246 
CSB in the GW region where IG astroglial RGC prescursors reside (Fig 1B with boxed area 247 
shown as higher magnification inset with arrows indicating Hs2st+ puncta) with the density 248 
falling towards the pial surface although Hs2st+ puncta were visible. There were many Hs2st+ 249 
puncta in the VZ of the cerebral cortex (Fig 1C) and also in the cortical plate (Fig 1D) 250 
indicating that many cortical progenitors and post-mitotic neurones express Hs2st. At E18.5 251 
Hs2st is expressed by many cells in the IG (Fig 1F) and at the apical surface of the ventricular 252 
zone (VZ) at the GW (Fig 1G), septum (Fig 1H), and ventral telencephalon (Fig 1I) with the 253 
number of Hs2st expressing VZ cells diminishing as distance from the ventricle increases. In 254 
the cerebral cortex Hs2st is expressed by many cells close to the apical surface of the VZ (Fig 255 
1J). Large numbers of post-mitotic cortical neurons outside the VZ express Hs2st and moving 256 
towards the pial suface the density of Hs2st+ puncta varies with laminar position (compare 257 
Fig 1 K,L,M showing relatively high Hs2st+ puncta density in cortical layers adjacent to the 258 
pial membrane (M) and in the intermediate zone (K) and lower density in the intervening 259 
region (L)). We validated the Hs2st antibody by demonstrating absence of the punctate 260 
Hs2st+ immunostaining in Hs2st-/- embryonic material (compare Fig 1N,P to O,Q – note that 261 
the more diffuse staining persists in Hs2st-/- tissue and we discounted this as non-specific 262 
background) and western blot showing that the predicted 42kDa Hs2st protein band was 263 
present in Hs2st+/+ and absent from Hs2st-/- telencephalic protein extracts (Fig 1R). To 264 
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conclude, Hs2st protein is present in developing cerebral cortex, the source of CC axons, as 265 
well as in progenitor and post-mitotic cells of the CSB region constituting the environment 266 
through which midline crossing CC axons navigate. The Hs2st expression analysis suggests 267 
multiple potential sites of action for 2-O HS sulphation in CC development.   268 
 269 
The Slit2 expressing IG is expanded in Hs2st-/- embryos. 270 
 We previously reported that increased numbers of astroglia at the pial surface of the 271 
Hs2st-/- CSB stemmed from precocious glial translocation and found no evidence that 272 
changes in cell proliferation or death contributed to this phenotype (Clegg et al., 2014; 273 
Conway et al., 2011). In order to determine whether there is an expansion of the IG in Hs2st-/- 274 
embryos we compared the expression of Slit2 mRNA, a marker of GW and IG glia but not 275 
MZ glia, between Hs2st+/+ and Hs2st-/- embryos at E16.5 (Shu and Richards, 2001; Shu et al., 276 
2003). In Hs2st+/+ embryos Slit2+ cells form a compact focus at the IG that increases in size 277 
moving caudally (Fig 2 A,C,E – Slit2 expression domain at IG indicated by brackets). In 278 
Hs2st-/- embryos the Slit2 expression domain is greatly expanded at the pial surface along the 279 
rostro-caudal axis (Fig 2 B,D,F – expanded Slit2 expression domain indicated by brackets). 280 
We conclude that an expansion of the Slit2+ IG astroglial population makes a major 281 
contribution to the Hs2st-/- phenotype. 282 
 283 
Cell autonomy of HS and 2-O HS sulphation in astroglial precursor somal translocation 284 
and corpus callosum development. 285 
We next exploited conditional mutagenesis of Hs2st or Ext1 to experimentally 286 
uncouple specific functions of 2-O sulphation from more general functions of HS in astroglial 287 
precursor translocation and corpus callosum development. Widespread expression of HS and 288 
2-O HS sulphation leaves open the possibility that each regulates GW→IG astroglial 289 
precursor somal translocation cell autonomously by modulating the response to signals, non 290 
cell autonomously by regulating the supply of signals, or both. To resolve this we identified 291 
two Cre alleles, Zic4Cre and Emx1CreER, that drive LoxP mediated mutagenesis in the 292 
astroglial lineage or in their cellular environment respectively and used them to conditionally 293 
ablate either HS (Ext1LoxP mutagenesis) or 2-O HS sulphation (Hs2stLoxP mutagenesis) to test 294 
for cell autonomous or non cell autonomous functions. We refer to these as ‘Zic4 lineage’ and 295 
‘Emx1 lineage’ and next present their characterisation using a floxed-stop GFP reporter that 296 
turns on GFP expression in Cre expressing cells and their descendants before describing 297 
experiments where they are employed to conditionally generate loss of function mutations in 298 
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Ext1Fl or Hs2stFl alleles (Inatani et al., 2003; Kessaris et al., 2006; Rubin et al., 2010; Sousa 299 
et al., 2009; Stanford et al.). 300 
 301 
Characterisation of Zic4 and Emx1 lineages. 302 
The septum is of Zic4 lineage, as shown by strong expression of the GFP reporter (Fig 303 
3A). The GFP signal in the intermediate zone of the cerebral cortex (asterisks, Fig. 3A) is due 304 
to GFP+ thalamocortical axons that project from Zic4 lineage cells in the thalamus and cells 305 
of sub-cortical origin as previously reported (Rubin et al., 2010). At the midline GFP+ cells of 306 
the Zic4 lineage are predominantly located ventral to the CSB (dashed lines in Fig 3B) but 307 
there is also GFP expression in the IG (boxed area ‘D’ in Fig 3B). Sox9 is a transcription 308 
factor that marks the nuclei of RGCs in the VZ and differentiated astroglia in the IG and 309 
MZG and we previously showed that the positioning of Sox9+ cells is of critical importance 310 
for the development of the CC (Clegg et al., 2014). Combining GFP with Sox9 311 
immunostaining reveals the contribution of the Zic4 lineage to the CSB astroglial 312 
populations. There is a sharp boundary (dashed line in Fig 3C) in the VZ of the CSB between 313 
Sox9+;GFP+ cells (arrowheads in Fig 3C) on the septal side and Sox9+;GFP- cells (arrows in 314 
Fig 3C) on the cortical side. Virtually all the Sox9+ cells in the IG (Fig 3D) and MZG (fig 3E) 315 
are also GFP+ (arrowheads in Fig 3D,E) indicating that these cells are Zic4 lineage. These 316 
data show that the Zic4 lineage contributes Sox9+ cells to the septal VZ and strikingly is the 317 
sole source of Sox9+ astroglia in the IG (Fig 3F). 318 
To mark the Emx1 lineage, tamoxifen was administered to Emx1CreER embryos 319 
harbouring the floxed-stop GFP reporter at E9.5 so that early Emx1 expressing cerebral 320 
cortex progenitors and their descendants were rendered GFP+. Examination of the expression 321 
of the GFP reporter shows that, as expected, the developing cerebral cortex and CC axons are 322 
of Emx1 lineage (Fig. 3G) and that at the midline GFP expression is predominantly located 323 
dorsal to the CSB (dashed lines in Fig 3H). Higher magnification shows that there is a sharp 324 
boundary between GFP+ and GFP- cells at the VZ of the CSB (dashed line in Fig 3I). 325 
Combining Sox9 and GFP immunostaining reveals the contribution of the Emx1 lineage to 326 
Sox9+ cells.  Sox9+;GFP+ cells (arrowheads in Fig 3I) populate the VZ on the cortical side of 327 
the boundary with Sox9+;GFP- cells on the septal side (arrows in Fig 3I) showing that the 328 
Emx1 lineage contributes Sox9+ cells exclusively to the cortical side of the VZ. All Sox9+ 329 
cells in the IG (Fig 3J) and MZ (Fig 3K) are GFP- (arrows in Fig 3J,K) indicating that the 330 
Emx1 lineage does not contribute Sox9+ cells to the IG. These data show that the Emx1 331 
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lineage contributes Sox9+ cells to the cortical VZ but no cells of this lineage contribute Sox9+ 332 
astroglia to the IG (schema in Fig 3L). 333 
 334 
Ext1 is required by both Emx1 and Zic4 lineage cells for corpus callosum development. 335 
 To determine the cellular requirement for HS we deleted Ext1, essential for HS 336 
synthesis, in the Zic4 or Emx1 lineages. In control embryos L1 immunostaining labels axons 337 
in the U-shaped CC while GFAP staining labels midline astroglial structures (Fig. 4A with 338 
higher magnification of IG and GW in Fig 4D,G). Removing HS from either the Zic4 lineage 339 
(Fig 4B with higher magnification of IG and GW in Fig 4E,H) or the Emx1 lineage (Fig 4C 340 
with higher magnification of IG and GW in Fig 4F,I) generates a severe CC agenesis 341 
phenotype  (Zic4Cre;Ext1Fl/Fl n=4/4; Emx1CreER;Ext1Fl/Fl n=3/3). In Emx1 conditional mutants 342 
(Emx1CreER;Ext1Fl/Fl) CC axons fail to cross the midline and form Probst bundles (P) some 343 
distance short of the midline (Fig. 4B). GFAP+ astroglial cells are present in the IG (Fig 4E) 344 
and at the GW (fig 4H) in a pattern grossly similar to that of controls (compare Fig. 4D,G to 345 
E,H). In Zic4 conditional mutants (Zic4Cre;Ext1Fl/Fl) CC axons approach the midline but fail 346 
to cross (Fig. 4C with higher magnification of IG and GW in Fig 4F,I). Astroglial populations 347 
in Zic4 conditional mutants are obviously disrupted with less intense GFAP staining at the 348 
midline (compare IG region in Fig 4 D to F) and more GFAP at the GW than in controls 349 
(arrows in Fig 4I, compare Fig. 4G to I) suggesting that in these embryos astroglial 350 
precursors translocate less efficiently to the IG and instead remain in the GW.  We noted that 351 
the cerebral cortex of Zic4Cre;Ext1Fl/Fl brains was thinned and the ventricles were enlarged 352 
(compare Fig4 A to C), this hydrocephalus-like phenotype is intriguing because the cerebral 353 
cortex is not of the Zic4 lineage indicating a non-cell autonomous mechanism by which HS 354 
regulates cerebral cortex development. The FGFR1/ FGF2 ligand and carbohydrate 355 
engagement (LACE) assay detects endogenous HS on tissue sections by forming ternary 356 
complexes with exogenously added FGF2 and FGFR1 (red LACE signal in Fig 4 J-O) (Allen 357 
et al., 2001; Chan et al., 2015). HS is ubiquitously expressed in both cortical and septal 358 
compartments of control telencephalon (Fig 4J, higher magnification of CSB in M) and, as 359 
intended, HS synthesis is blocked in the cortex and cortical axons of Emx1CreER;Ext1Fl/Fl 360 
embryos (Fig 4K, CSB shown at higher magnification in N with arrows indicating HS 361 
deficient cortical region) and in the septum of Zic4Cre;Ext1Fl/Fl  embryos (Fig 4L, higher 362 
magnification of CSB in O with arrows indicating HS deficient septum). Predigesting tissue 363 
sections with heparitinase eliminated the LACE signal (not shown) confirming specificity of 364 
this assay for detecting HS. The salient conclusions from the Ext1 conditional mutagenesis 365 
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for the current study are that HS is indispensable from both the Zic4 and the Emx1 lineages 366 
for CC development and that removing HS from the Zic4 lineage inhibits Zic4 lineage 367 
astroglia reaching the IG region. 368 
 369 
Hs2st is required by Emx1 lineage but not Zic4 lineage cells for corpus callosum 370 
development. 371 
 Having established that both Zic4 and Emx1 lineages need to synthesise HS for 372 
normal CC development we next asked whether 2-O HS sulphation of the HS is required in 373 
either lineage. Hs2st is the sole enzyme capable of imparting 2-O HS sulphation onto HS so 374 
to determine the cellular requirement for 2-O HS sulphation we deleted Hs2st in the Zic4 or 375 
Emx1 lineages. Control Hs2st+/+ genotypes (Hs2st+/+;Emx1CreER and Hs2st+/+;Zic4Cre) 376 
displayed neither CC agenesis nor midline astroglial disorganisation, the control embryo 377 
shown in Fig 5 (A,D,G,J – D,G reproduced from Fig 3 H,J) is Hs2st+/+;Emx1CreER genotype. 378 
The CC and the midline astroglial structures form normally in Hs2stfl/fl;Zic4Cre conditional 379 
mutants and the organisation of L1+ axons and GFAP+ astroglia are indistinguishable from 380 
control embryos (6/6 embryos) (Fig. 5B, compare to control in 5A). The organisation of 381 
GFP+ Zic4 lineage cells is the same in Hs2stfl/fl;Zic4Cre embryos as in Hs2st+/+;Zic4Cre 382 
embryos (compare Fig 5E,H to Fig 3B,D) and IG Sox9+ cell counts confirm that the numbers 383 
of Sox9+ cells in the IG are not significantly different to control Hs2st+/+ embryos (Fig 5M, 384 
compare blue and orange bars) indicating no cell autonomous requirement for Hs2st in the 385 
Zic4 lineage Sox9+ IG astroglia. To exclude the possibility of a compensatory mechanism by 386 
which the Hs2stfl/fl;Zic4Cre IG is populated by Hs2st+/+ cells from a different lineage we 387 
performed Hs2st immunohistochemistry and confirmed that Hs2st expression is indeed 388 
absent from all cells in the IG (Fig 5K, note this is an adjacent section from the same embryo 389 
to the one shown in 5H). In Hs2stfl/fl;Emx1CreER embryos the CC fails to form in 390 
approximately 50% of cases, embryos either had a severe phenotype (Fig 5C, 5/9 embryos) or 391 
appeared completely unaffected (Fig 5C’, 4/9 embryos). CC axons form Probst bundles (P) 392 
on either side of the telencephalic midline while the GFAP+ IG is expanded (asterisks, Fig. 393 
5C). The anatomy and incomplete penetrance of the CC phenotype in Hs2stfl/fl;Emx1CreER 394 
embryos closely resemble constitutive null Hs2st-/- embryos indicating that Hs2st function 395 
within the Emx1 lineage is sufficient for normal CC development (Clegg et al., 2014; 396 
Conway et al., 2011). As in control Hs2st+/+;Emx1CreER embryos (Fig 5 D,G) the GFP and 397 
Sox9 signals did not overlap in the IG region of control or Hs2stfl/fl;Emx1CreER embryos (Fig 398 
5F, boxed area shown at higher magnification in 5I) and the Sox9+ cells in the IG of control 399 
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embryos and the expanded IG of Hs2stfl/fl;Emx1CreER embryos were GFP- (arrows in Fig 5I 400 
indicate Sox9+;GFP- cells). Counts of Sox9+ cells confirmed a significant increase in the IG 401 
of affected Hs2stfl/fl;Emx1CreER embryos compared to controls (Fig 5M, compare blue and 402 
purple bars). Immunostaining for Hs2st on adjacent sections confirmed that IG cells in 403 
Hs2stfl/fl;Emx1CreER embryos retain Hs2st protein expression (Fig 5L).  Because Sox9+ IG 404 
astroglia do not belong to the Emx1 lineage their ectopic position in Hs2stfl/fl;Emx1CreER 405 
embryos, despite retaining Hs2st function, allows us to conclude a cell non autonomous 406 
requirement for Hs2st in the translocation of astroglial precursors to the IG..  407 
The salient conclusions from these conditional mutagenesis experiments are that 408 
while the Zic4 lineage astroglia do require Ext1 to form midline astroglial structures they do 409 
not require Hs2st, strongly suggesting that while these Zic4 lineage cells require HS on their 410 
cell surface to respond to translocation signals there is no need for the HS to be 2-O 411 
sulphated. In contrast Hs2st is absolutely required in the surrounding Emx1 lineage cells 412 
indicating a non cell autonomous mechanism by which 2-O HS sulphation controls the 413 
transmission of translocation signals to the Zic4 lineage astroglial precursors. 414 
 415 
Hs2st is not required cell autonomously by CC axons to navigate the midline. 416 
 The conditional mutagenesis experiments showed that Hs2st has a non cell 417 
autonomous role in GW→IG somal translocation, but, because Hs2st is expressed throughout 418 
the cerebral cortex, did not resolve whether there is an additional cell autonomous 419 
requirement in CC axon navigation. To answer this we performed ex vivo transplant 420 
experiments in which cerebral cortical tissue from transgenic mice ubiquitously expressing 421 
τGFP, which efficiently labels axons of τGFP+ cells, was transplanted into τGFP- 422 
telencephalic slices containing the CC axon pathway and CSB structures (Niquille et al., 423 
2009; Pratt et al., 2000). When wild-type (WT) E17.5 τGFP+ cortical explants are transplanted 424 
into age matched τGFP- WT cortical slices τGFP+ axons extend across the telencephalic 425 
midline forming the characteristic U-shape of the CC and reach the cortex of the opposite 426 
hemisphere (n=3/3 cultures, arrows in Fig 6A,D point to crossing axons). When Hs2st-/- 427 
τGFP+ cortical explants are transplanted into τGFP- WT slices, axons are able to cross the 428 
midline to reach the opposite hemisphere in a manner indistinguishable from that seen in the 429 
WT→WT transplants (n=4/4 cultures, arrows in Fig 6B,E point to crossing axons). In 430 
contrast, when τGFP+ WT cortical explants are transplanted into τGFP-  Hs2st-/- slices axons 431 
are unable to reach the opposite cortical hemisphere and instead remain within the cingulate 432 
cortex or invade the septum (n=6/6 cultures), resembling the in vivo CC phenotype observed 433 
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in Hs2st-/- embryos (Clegg et al., 2014; Conway et al., 2011). Note that in all cultures a few 434 
axons grew into the septum (arrowheads in Fig 6 D,E,F). Schematics summarising these 435 
experiments are shown in Fig 6 G,H,I. These data show 2-O HS sulphation is not required 436 
cell autonomously by CC projection neurons for axon guidance across the midline strongly 437 
suggesting that disorganisation of midline guidepost astroglial cells is the primary cause of 438 
the Hs2st-/- CC agenesis phenotype. 439 
 440 
Abnormally high FGF/ERK signalling causes the Hs2st-/- precocious astroglial 441 
translocation phenotype. 442 
 We previously reported a correlation between hyperactive ERK signalling at the CSB 443 
and precocious somal translocation of astroglia to the midline in Hs2st-/- embryos but we did 444 
not formally establish that this stemmed from hyperactive FGF/ERK signalling (Chan et al., 445 
2017; Clegg et al., 2014). To address this we employed an ex vivo assay in which coronal WT 446 
or Hs2st-/- telencephalic slices incorporating the CSB were cultured on floating membranes 447 
for long enough to allow somal translocation to the midline and attempted to rescue the 448 
Hs2st-/- phenotype by pharmacological abrogation of FGF/ERK signalling. WT or Hs2st-/- 449 
E14.5 slices were cultured in the presence of the Fgfr1 inhibitor SU5402 dissolved in DMSO 450 
(FGFi treatment) to inhibit FGF/ERK signalling or in DMSO alone (untreated control) for 451 
48hr (Fig 7A). To aid subsequent identification of translocating cells, a subpopulation RGCs 452 
undergoing S-phase in the VZ at E14.5 were labelled just prior to culturing with a single 453 
pulse of BrdU. Immunohistochemistry for pErk (brown stain in Fig 7 B,D,F,H) confirms 454 
inhibition of FGF/ERK signalling in both FGFi treated WT and Hs2st-/- cultures (Fig 7D,H) 455 
compared to untreated cultures (Fig 7B,F) showing that FGF signalling through Fgfr1 456 
accounts for ERK phosphorylation in both genotypes so, importantly, demonstrating that 457 
ERK hyperactivation in Hs2st-/- embryos does not stem from an FGF-independent mechanism 458 
for ERK activation (Chan et al., 2017; Clegg et al., 2014). After 48 hours some Sox9+ cells 459 
(red) had left the VZ and translocated to the midline in untreated WT cultures (arrow in Fig 460 
7C) with many more populating the midline in untreated Hs2st-/- cultures (arrow in Fig 7G) 461 
validating that our ex vivo assay replicates the in vivo Hs2st-/- phenotype. Consistent with our 462 
hypothesis, FGFi treatment of both WT and Hs2st-/- cultures resulted in a large decrease in 463 
Sox9+ cells reaching the midline (compare Fig 7E,I to C,G). We quantified glial translocation 464 
by counting the numbers of Sox9+ cells born in the VZ at E14.5 (Sox9+;BrdU+ cells, yellow – 465 
inset in Fig 7 C,E,G,I shows higher magnification) that had exited the VZ towards the 466 
midline (VZ demarcated by dotted line in Fig 7 C,E,G,I) after 2 days in culture. Counts of 467 
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BrdU+;Sox9+ cells showed that glial translocation was significantly greater in Hs2st-/- 468 
compared to WT cultures along the rostro-caudal axis (dark purple and green lines in Fig 7J) 469 
and in both cases almost completely suppressed by FGFi treatment (pale purple and green 470 
lines in Fig 7J).  471 
We conclude that the precocious glial translocation phenotype in Hs2st-/- embryos is 472 
caused by hyperactive FGF/ERK signalling from E14.5 onwards. Taken together with our 473 
Hs2st conditional mutagenesis experiments demonstrating a non cell autonomous role for 474 
Hs2st in astroglial precursor translocation we hypothesise that Hs2st normally suppresses the 475 
supply of FGF proteins to translocation competent astroglial precursors in the GW. 476 
 477 
 478 
Hs2st suppresses Fgf17 protein levels. 479 
We next sought to identify an FGF protein that is targeted by Hs2st. Despite its well 480 
known role in CC development Fgf8 protein levels are not significantly increased at the CSB 481 
of Hs2st-/- embryos forcing us to consider other FGFs (Chan et al., 2017; Clegg et al., 2014). 482 
A promising candidate is Fgf17, a member of the Fgf8 subfamily transcribed at the CSB in a 483 
similar pattern to Fgf8 (Cholfin and Rubenstein, 2008; Zhang et al., 2012b). Fgf17 is a 484 
canonical FGF that binds to HS, so is potentially regulated via its interaction with HS, and is 485 
known to play a role in patterning the telencephalon although its role in CC development has 486 
not been fully characterised (Cholfin and Rubenstein, 2007; Hoch et al., 2015; Li and 487 
Kusche-Gullberg, 2016). We hypothesised that Hs2st normally suppresses Fgf17 protein and 488 
predicted that Fgf17 protein levels would be increased at the Hs2st-/- CSB. We compared the 489 
expression of Fgf17 protein in the developing CSB of WT and Hs2st-/- embryos at three 490 
developmental stages (E12.5, E14.5, and E16.5), spanning the interval of midline glial 491 
translocation (Fig 8A1,2-H1,2). At E12.5 telencephalic Fgf17 protein is restricted to the CSB 492 
region with no obvious difference between WT and Hs2st-/- (compare Fig 8 A1,B1 to A2,B2). 493 
By E14.5 there is an expanded Fgf17 protein domain at the CSB of Hs2st-/- embryos 494 
(compare Fig 8 D1,E1 to D2,E2, * in E2 marks the expanded Fgf17 protein domain). 495 
Quantification of Fgf17 immunofluorescence shows a significant ~2 fold increase in Fgf17 496 
protein levels in this region of Hs2st-/- CSB (Fig 8W – compare blue and green bars).  At 497 
E16.5 Fgf17 protein is much closer to detection threshold than at the earlier stages in both 498 
genotypes (Fig 8G1,2,H1,2) although the increased protein spread in the mutant persists (* in 499 
Fig 8H2) indicating that the Hs2st-/- CSB is exposed to a prolonged overdose of Fgf17 protein 500 
spanning E14.5-E16.5. We next examined Fgf17 mRNA at the CSB so see whether the 501 
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increase in Fgf17 protein in Hs2st-/- CSB was underpinned by altered Fgf17 gene expression. 502 
There was no evidence for this at E12.5 or E14.5 where Fgf17 mRNA expression pattern 503 
remains similar between Hs2st+/+ and Hs2st-/- embryos (compare Fig 8 C1 to C2 and F1 to F2), 504 
however, the expression domain of Fgf17 mRNA is increased in E16.5 Hs2st-/- CSB 505 
(compare Fig 8I1 to I2, * in I2 marks expanded Fgf17 mRNA domain). This subsequent 506 
increase in Fgf17 mRNA in the E16.5 Hs2st-/- CSB indicates that the Hs2st-/- phenotype has a 507 
transcriptional component or that there are more cells expressing Fgf17 mRNA in the 508 
expanded Hs2st-/- IG although this cannot be the primary event as it is not apparent at E14.5, 509 
the stage at which we previously identified precocious astroglial precursor translocation was 510 
well underway in Hs2st-/- embryos (Clegg et al., 2014).  511 
 Mosaic analysis (Fig 5) indicated that Hs2st function in the Emx1 lineage negatively 512 
regulates a signal promoting GW→IG translocation of Zic4 lineage glial cells by a non cell 513 
autonomous mechanism and Fgf17 expression analysis (Fig 8) makes Fgf17 a strong 514 
candidate for the signal. Based on this we hypothesised that Fgf17 is expressed in cells 515 
surrounding the  Zic4 lineage cells and performed detection of Fgf17 mRNA or protein in 516 
E14.5 WT embryos in which the Zic4 lineage is labelled GFP+. Fgf17 mRNA is expressed at 517 
the GW and the IG (Fig 8J) and higher power magnification shows that in the VZ GFP+ cells 518 
express little if any Fgf17 mRNA and conversely cells expressing the highest levels of Fgf17 519 
mRNA are GFP- (Fig 8 K1-3, arrows indicate GFP+ cell location). This complementarity 520 
between Fgf17 mRNA expressing and Zic4 lineage cells is preserved at the IG (Fig 8L1-3, 521 
arrows indicate GFP+ cell location). Fgf17 protein predominates at the IG (Fig 8M) and 522 
higher power magnification shows that while Fgf17 protein is barely detectable at the GW 523 
(Fig 8N1-3) there are a number of much higher Fgf17 expressing cells at the IG and these cells 524 
are GFP- confirming that they do not belong to the Zic4 lineage (Fig 8O1-3, arrows indicate 525 
GFP+ cell location). Interestingly, although cells in the GW and IG express comparable levels 526 
of Fgf17 mRNA (compare Fig 8K1 to L1) the expression of Fgf17 protein is much higher in 527 
the IG (compare Fig 8N1 to O1) suggesting a post-transcriptional repression selectively at the 528 
GW. Our identification of Hs2st as a repressor of Fgf17 protein levels at this stage makes 529 
Hs2st a strong candidate, indeed, closer examination of Hs2st expression using the Hs2st-530 
LacZ reporter shows that Hs2st is expressed in a GWHigh-IGLow pattern (Fig 8P, also apparent 531 
in the Hs2st immunohistochemistry (Fig 1B)), complementary to the GWLow-IGHigh Fgf17 532 
protein distribution. Together these data bolster the idea that Hs2st acts to suppress Fgf17 533 
protein supply to Zic4 lineage cells by a post-transcriptional mechanism.  534 
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We conclude that Hs2st primarily supresses the level and spread of Fgf17 protein 535 
emanating from the Emx1 lineage in the CSB. 536 
 537 
Hs6st1 does not affect Fgf17 protein levels. 538 
We next addressed whether the ability of 2-O HS sulphation to supress Fgf17 protein 539 
levels in vivo represented a specific function of Hs2st or was redundant with other HSTs. We 540 
chose to examine Hs6st1, an HST that catalyses 6-O HS sulphation, because we have 541 
previously shown that Hs6st1 (but not Hs2st) supresses levels of the closely related Fgf8 542 
protein at the CSB in vivo (Chan et al., 2017; Clegg et al., 2014). However, we were unable 543 
to detect increased expression of Fgf17 protein (compare Fig 8 Q1, R1 to Q2, R2 and T1, U1 to 544 
T2, U2) or Fgf17 mRNA (compare Fig 8S1 to S2 and V1 to V2) in Hs6st1-/- compared to wild-545 
type CSB at either E14.5 or E16.5. Quantification of Fgf17 immunofluorescence shows 546 
unchanged Fgf17 protein levels in this region of Hs6st1-/- CSB (Fig 8W – compare blue and 547 
purple bars). These data demonstrate that the negative relationship between Hs2st and Fgf17 548 
is selective in vivo because it does not apply to Hs6st1.  549 
 550 
Exogenously applied Fgf17 phenocopies the Hs2st-/- astroglial translocation phenotype. 551 
Our data suggest that the Hs2st-/- phenotype stems from abnormally high levels of 552 
Fgf17 protein at the CSB causing FGF/ERK hyperactivation and precocious somal 553 
translocation to the IG. This requires that Hs2st-/- CSB cells are competent to respond to 554 
Fgf17 protein and that application of ectopic Fgf17 triggers precocious glial translocation, 555 
neither of which have been previously established. We redeployed the CSB ex vivo culture 556 
assay (see Fig 7) with the modification that beads soaked in either recombinant Fgf17 protein 557 
(Fgf17 treatment) or in BSA (control) were implanted into coronal slices of CSB region on 558 
either side of the midline (Fig 9A). WT or Hs2st-/- slices implanted with Fgf17 and BSA 559 
beads were cultured for 2 hours before processing for Fgf17 (green signal) and pErk (red 560 
signal) double immunofluorescence (Fig 9B). In both WT and Hs2st-/- cultures Fgf17 protein 561 
was detectable adjacent to the edge of the bead (green signal) and this activated ERK 562 
phosphorylation in a similar pattern (red signal) with no obvious differences between WT and 563 
Hs2st-/- indicating that Hs2st-/- CSB tissue is competent to respond to Fgf17 (Fig. 9B top 564 
row). The lack of Fgf17 or pERK signal in the BSA control (Fig 9B, bottom row) confirms 565 
Fgf17 antibody specificity and that pERK activation was specifically induced by exogenously 566 
applied Fgf17. We performed Sox9/BrdU analysis (exactly as described above for the FGFi 567 
experiments - Fig 7) to assess the impact of experimentally introduced Fgf17 on astroglial 568 
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translocation to the midline after 48 hours in culture. The results were dramatic, the side with 569 
the Fgf17-bead showed many more Sox9+ (red) cells in the IG region (large arrow on right 570 
side of Fig 9C) than the side with the BSA bead (smaller arrow on left side of Fig9C). 571 
Quantification of Sox9+;BrdU+ (yellow) cells (Fig 9D shows higher magnification of IG 572 
region) confirmed a significant increase in astroglial translocation to the midline along the 573 
rostro-caudal axis on the side exposed to Fgf17 (Fig 9E, compare green (Fgf17) to black 574 
(control) lines). An important function of IG glia is to secrete Slit2 and repulsively guide CC 575 
axons in the correct trajectory across the midline. At E16.5 Slit2 mRNA is normally 576 
expressed in the IG region and in Hs2st-/- embryos the midline Slit2 expression domain is 577 
expanded (compare Fig 2C,E to D,F – Slit2 expression domain bracketed). Experimentally 578 
introduced Fgf17 is sufficient to phenocopy this aspect of the Hs2st-/- phenotype in our ex 579 
vivo assay as the side exposed to the Fgf17 bead has a much larger Slit2 domain than the BSA 580 
treated side (compare left (Fgf17) and right (control) bracketed areas in Fig 9F) consistent 581 
with precocious translocation of excessive numbers of Slit2+ IG glia.  582 
We conclude that Hs2st-/- CSB tissue is competent to respond to Fgf17 protein and 583 
abnormally high levels of Fgf17 protein are sufficient to phenocopy the Hs2st-/- astroglial 584 
translocation phenotype consistent with the model presented in Fig 10. 585 
 586 
Hs2st selectively facilitates physical interaction between Fgf17 protein and HS. 587 
Our in vivo data show that Hs2st suppresses the levels of Fgf17 protein and that this 588 
represents a selective interaction between Hs2st mediated 2-O HS sulphation and Fgf17 589 
protein levels in vivo because Hs2st does not suppress the levels of the closely related Fgf8 590 
protein while Hs6st1, which catalyses 6-O HS sulphation, does not suppress Fgf17 protein 591 
levels (Chan et al., 2017; Clegg et al., 2014), Fig 8). These in vivo experiments do not 592 
however resolve whether differential sulphation has a correspondingly direct selective effect 593 
on the physical interaction between HS and Fgf17. In order to test the hypothesis that Hs2st 594 
has a selective effect on the binding of Fgf17 protein to HS molecules we turned to a 595 
biochemical assay, the ligand and carbohydrate engagement (LACE) assay, that probes 596 
physical interaction between HS and FGF proteins by quantifying the ability of endogenous 597 
HS in tissue sections to form Fgf:Fgfr:HS complexes with exogenously added Fgf protein 598 
and Fgfr ectodomain fused to an Fc tag for immunofluorescent detection (Allen et al., 2001; 599 
Chan et al., 2015). We used the Fgf17:Fgfr1 LACE assay to compare the binding of Fgf17 600 
protein to HS in WT, Hs2st-/- and Hs6st1-/- CSB tissue at E14.5 and E16.5 in order to test the 601 
hypothesis that Fgf17:HS physical interaction is selectively sensitive to loss of 2-O HS 602 
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sulphation in Hs2st-/- tissue (Fig 11 A-J, O). We used the Fgf8:Fgfr3 LACE assay to compare 603 
the binding of Fgf8 protein to HS in WT and Hs2st-/- CSB tissue at E14.5 and E16.5 to test the 604 
hypothesis that the Fgf8:HS physical interaction is insensitive to loss of 2-O HS sulphation in 605 
Hs2st-/- tissue (Fig 11 K-N, P).  606 
In both E14.5 and E16.5 WT tissue the Fgf17:Fgfr1 and Fgf8:Fgfr3 LACE assays 607 
produced a strong LACE signal (Fig 11 A,F,K with higher magnification of boxed areas 608 
enclosing CSB region shown in A’, F’, K’). Control experiments show this LACE signal was 609 
drastically reduced by pre-treating the tissue with heparinitase to digest HS (Fig 11 D,I,M, 610 
with higher magnification of CSB in D’,I’,M’) or omitting Fgf17 or Fgf8 protein from the 611 
assay (Fig 11 E,J,N with higher magnification of CSB in E’,J’,N’). Together these controls 612 
confirm the LACE signal provides a specific readout of the interaction between each FGF 613 
protein and HS molecules. To determine the effect of differential sulphation on the physical 614 
interaction between HS and Fgf8 or Fgf17 we examined how the LACE signal was affected 615 
when the assay was performed on Hs2st-/- and Hs6st1-/- tissue. As predicted by our hypothesis 616 
the binding of Fgf17 to HS is selectively sensitive to 2-O HS sulphation as we found that the 617 
Fgf17:Fgfr1 LACE signal was much weaker than WT in Hs2st-/- tissue (compare B,B’,G,G’ to 618 
A,A’,F,F’) but similar to WT in Hs6st1-/- tissue (compare C,C’,H,H’ to A,A’,F,F’). 619 
Quantification of Fgf17:Fgfr1 LACE signal intensity in Fig 11 O shows a significant ~4-fold 620 
reduction in Hs2st-/- (green bar) compared to WT (blue bar) but no significant difference to 621 
WT in Hs6st1-/- (purple bar). As predicted by our hypothesis that the binding of Fgf8 to HS is 622 
not sensitive to 2-O HS sulphation we found that there was no difference in the Fgf8:Fgfr3 623 
LACE signal between WT and Hs2st-/- tissue (compare Fig 11 K,K’ to L,L’). Quantification 624 
of Fgf8:Fgfr3 LACE signal intensity in Fig 11 P shows no significant difference between 625 
Hs2st-/- (green bar) compared to WT (blue bar). These LACE results are summarised 626 
schematically in Fig 11Q which shows that of the five HST genotype and FGF ligand 627 
permutations tested only the Fgf17:HS physical interaction is sensitive to Hs2st genotype, as 628 
predicted by the hypothesis that 2-O HS sulphation has a specific effect on the ability of HS 629 
to bind Fgf17. 630 
 631 
Discussion 632 
 Embryonic corpus callosum (CC) development involves multiple cell and molecular 633 
events that ultimately guide callosal axons across the telencephalic midline to connect with 634 
their synaptic targets in the contralateral hemisphere. Three subpopulations of midline 635 
astroglia play pivotal roles in guiding callosal axons across the telencephalic midline. Midline 636 
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zipper (MZ) glia facilitate fusion of the cerebral hemispheres and provide a substrate for 637 
crossing callosal axons while Slit2+ indusium griseum (IG) and glial wedge (GW) astroglia 638 
channel crossing axons into the correct path by Robo/Slit mediated chemorepulsion (Bagri et 639 
al., 2002; Gobius et al., 2016; Shu and Richards, 2001; Shu et al., 2003). These astroglial 640 
populations originate from RGCs born in the VZ of the septal midline and either remain in 641 
the VZ at the glial wedge (GW astroglia) or translocate in response to FGF signals, of which 642 
Fgf8 appears to be particularly important, to the pial surface of the telencephalic midline (MZ 643 
and IG astroglia) (Clegg et al., 2014; Gobius et al., 2016; Moldrich et al., 2010; Smith et al., 644 
2006). Both Slit2+ IG and Slit2- MZ astroglia are essential for CC development and both 645 
these astroglial populations originate from the septal VZ Zic4 lineage so the lack of an overt 646 
CC phenotype in Hs2stFl/Fl;Zic4Cre embryos following conditional knockout of Hs2st in the 647 
Zic4 lineage indicates that neither MZ or IG astroglial precursors have a cell autonomous 648 
requirement for Hs2st to translocate in appropriate numbers. In Hs2st-/- embryos there is an 649 
expansion of the Slit2 expression domain at the CSB pial surface coinciding with increased 650 
Sox9+ glial cells and this is phenocopied by application of exogenous Fgf17 to Hs2st+/+ CSB 651 
ex vivo strongly suggesting increased numbers of Slit2+ glial cells at the midline reflect 652 
excessive GW→IG somal translocation enlarging the IG (current study). We cannot rule out 653 
the possibility that disrupted MZ glial translocation also contributes to the Hs2st-/- phenotype 654 
although this would not alter our conclusion that Hs2st plays a non-cell autonomous role in 655 
the Zic4-lineage astroglial translocation phenotype. Our model (Fig 10) posits that ectopic 656 
Slit2+ astroglia at the midline block the transit of CC axons. In principle this could be tested 657 
by rescuing the CC axon midline crossing in Hs2st-/-;Slit2-/- embryos (along similar lines to 658 
the Slit2 genetic rescue of the Hs6st1-/- phenotype we reported in Hs6st1-/-;Slit2-/- embryos 659 
(Conway et al., 2011)). However, in contrast to the fully penetrant (100%) Hs6st1-/- CC 660 
phenotype, the partial penetrance (~50%) of the Hs2st-/- CC phenotype introduces a 661 
confounding factor of distinguishing ‘rescued’ from ‘unaffected’ Hs2st-/- embryos, a problem 662 
that would be compounded if only a proportion of embryos destined to be ‘affected’ were 663 
rescued (see (Clegg et al., 2014; Conway et al., 2011)) so a prohibitively large number of 664 
animals would be required to demonstrate a statistically significant rescue. 665 
Eliminating HS (Ext1 mutagenesis) compared to 2-O HS sulphation (Hs2st 666 
mutagenesis) from the same cell lineages allowed us to distinguish physiological functions 667 
generally attributable to HS from those specifically requiring 2-O HS sulphation by 668 
comparing the Ext1 and Hs2st phenotypes. We found that while Zic4 lineage cells were 669 
unable to support CC development when they lacked HS (Zic4Cre;Ext1Fl/Fl embryos) there 670 
 21 
 
was no similar requirement for 2-O HS sulphation in the Zic4 lineage (Zic4Cre;Hs2stFl/Fl 671 
embryos) indicating that Zic4 lineage cells require HS but that 2-O HS sulphation is 672 
dispensible for their contribution to CC development, specifically the ability of astroglial 673 
precursors to cell autonomously sense translocation signals. We found that HS and 2-O HS 674 
sulphation are both required in the Emx1 lineage (Emx1CreER;Ext1Fl/Fl and 675 
Emx1CreER;Hs2stFl/Fl embryos) although the axonal and astroglial phenotypes were not 676 
identical. Somewhat counterintuitively, removing HS completely from the Emx1 lineage in 677 
Emx1CreER;Ext1Fl/Fl embryos had a less severe effect on the distribution of GFAP+ midline 678 
glia than preserving HS but blocking its 2-O sulphation, as the accumulation of astroglia at 679 
the pial surface of the midline was much more pronounced in Emx1CreER;Hs2stFl/Fl embryos. 680 
We speculate that completely removing HS from the Emx1 lineage results in a general 681 
destabilisation of FGF protein gradients so mitigating precocious somal translocation by Zic4 682 
lineage astroglial precursors (Chan et al., 2017; Qu et al., 2011; Qu et al., 2012; Shimokawa 683 
et al., 2011). The relatively normal midline astroglial organisation in Emx1CreER;Ext1Fl/Fl 684 
embryos poses the question of whether glial disorganisation is a major contributor to their CC 685 
agenesis phenotype. In Emx1CreER;Hs2stFl/Fl embryos the Probst bundles form right next to the 686 
midline, consistent with our hypothesis that ectopic Slit2+ astroglia at the midline are 687 
repelling CC axons from crossing the midline (Conway et al., 2011) & current study). In 688 
contrast the Probst bundles in Emx1CreER;Ext1Fl/Fl embryos form much more lateral to the 689 
midline at some distance from the IG indicating CC axons are misrouted at an earlier stage of 690 
their navigation than in Emx1CreER;Hs2stFl/Fl embryos. HS is required cell autonomously for 691 
navigating axons to respond to axon guidance molecules, including Netrin1 and Slit2 692 
(Matsumoto et al., 2007; Piper et al., 2006). A plausible explanation is that in 693 
Emx1CreER;Ext1Fl/Fl embryos the Emx1 lineage HS-deficient CC axons cannot respond 694 
appropriately to guidance cues that would normally guide them towards the midline and are 695 
already misrouted before they come under the influence of the midline astroglia In contrast 696 
Hs2st-/- CC axons express HS lacking 2-O sulphation that does not affect their ability to 697 
respond to guidance cues (current study) so they reach the midline but are prevented from 698 
crossing by the ectopic Slit2+ glia in the expanded IG. 699 
Biochemical (LACE) data shows that physical interaction between Fgf17 and HS is 700 
facilitated by Hs2st (but not Hs6st1) and that Hs2st facilitates physical interaction between 701 
HS and Fgf17 (but not Fgf8) suggesting a molecular mechanism underpinning Hs2st 702 
selectively suppressing levels of Fgf17 in vivo (Allen and Rapraeger, 2003; Chan et al., 2015; 703 
Chan et al., 2017; Clegg et al., 2014), current study). We speculate that Hs2st exerts its 704 
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selective effect on Fgf17 protein levels because HS lacking 2-O HS sulphation has reduced 705 
affinity for Fgf17 (but not Fgf8) so increasing the half-life of Fgf17 (but not Fgf8) in the 706 
ECM by selectively reducing the rate that Fgf17 protein is cleared by HS-mediated receptor 707 
mediated endocytostis of canonical FGFs while leaving Fgf8 unaffected (Yu et al., 2009). 708 
Our conditional mutagenesis experiments clearly demonstrate there is no cell autonomous 709 
requirement for Hs2st in astroglial precursor translocation in Emx1CreER;Hs2stFl/Fl embryos, 710 
however the reduced efficiency of HS:Fgf17:Fgfr1 complex formation in the LACE assay 711 
implies that Hs2st might also play a cell-autonomous role in the response to Fgf17 protein. 712 
We speculate that even if Hs2st-/- astroglial precursors are less sensitive to Fgf17 than their 713 
wild-type counterparts their translocation to the midline is primarily driven by Fgf8 so is not 714 
significantly affected in Zic4Cre;Hs2stFl/Fl embryos. A putative reduced sensitivity of Hs2st-/- 715 
astroglial precursor cells to Fgf17 also begs the question of how elevated Fgf17 could trigger 716 
precocious glial translocation in Hs2st-/- embryos. The Fgf17 bead assay experiment shows 717 
that Hs2st-/- cells retain competence to respond to Fgf17 by phosphorylating ERK and LACE 718 
data shows that HS devoid of 2-O HS sulphation still interacts with Fgf17 albeit with reduced 719 
efficiency. The explanation that best fits our experimental data, therefore, is that increased 720 
Fgf17 protein levels in Hs2st-/- embryos overrides any reduction in competency of Hs2st-/- 721 
cells to respond to Fgf17 protein and the net effect is elevated FGF/ERK signalling and 722 
consequent precocious astroglial translocation. 723 
This study makes two major novel contributions to our understanding of the cell and 724 
molecular roles of differential HS sulphation in the regulation of forebrain development. First 725 
that a primary cellular role of 2-O HS sulphation in vivo is not to modulate the competence of 726 
astroglial precursor cells to respond to translocation signals by a cell autonomous mechanism 727 
(as would be predicted by the classic role for HS in modulating the formation of the 728 
FGF:FGFR:HS receptor complex on the surface of responding cells) but instead to regulate 729 
the supply of translocation signals to astroglial precursors by a non cell autonomous 730 
mechanism. Second that the interaction between 2-O sulphated HS and Fgf17 protein is 731 
selective because it does not apply to the closely related Fgf8 protein or to 6-O HS sulphation 732 
catalysed by Hs6st1. The most parsimonious explanation linking these cell and molecular 733 
events is that higher than normal levels of Fgf17 protein at the CSB of Hs2st-/- embryos 734 
causes the precocious astroglial precursor translocation phenotype and subsequent misrouting 735 
of CC axons (Fig 10). Our rescue of the Hs2st-/- precocious astroglial precursor translocation 736 
phenotype ex vivo by generic pharmacological inhibition of FGF signalling with SU5402 737 
directly supports the hypothesis that hyperactive FGF/ERK signalling causes the phenotype. 738 
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Given the well known role of FGF/ERK signalling in triggering astroglial precursor 739 
translocation to the IG, our findings that exogenously applied Fgf17 protein is sufficient to 740 
phenocopy the Hs2st-/- astroglial precursor translocation phenotype, and that Hs2st-/- CSB 741 
cells activate ERK in response to Fgf17 protein, it is extremely unlikely that increased Fgf17 742 
protein levels in vivo wouldn’t result in ERK hyperactivation and consequent precocious 743 
astroglial precursor translocation in Hs2st-/- embryos. However, the current study does not 744 
provide formal proof that the elevated levels of Fgf17 protein are solely responsible for the 745 
FGF/ERK hyperactivation or precocious astroglial precursor translocation phenotypes in 746 
Hs2st-/- embryos and we were unable to design an experiment that could further discriminate 747 
between the functions of Fgf17 and Fgf8 and directly test functional selectivity of Hs2st for 748 
Fgf17 in this context. We considered employing a classic rescue experiment strategy by 749 
genetically reducing Fgf17 dosage in Hs2st-/- embryos (‘Fgf17-/-;Hs2st-/-‘ rescue) but on 750 
balance elected not to because at best it would provide equivocal evidence either for or 751 
against the hypothesis that 2-O sulphated HS interacts selectively with Fgf17 protein. 752 
FGF/ERK hyperactivation caused by overexpression of a particular FGF protein can be 753 
rescued by any experimental manipulation that restores ERK signalling to normal levels and 754 
not uniquely by restoring the levels of the FGF protein that underpins the phenotype. 755 
Specifically, reducing Fgf17 dosage could elicit a rescue of ERK hyperactivation and 756 
collateral phenotypes at the Hs2st-/- CSB by reducing FGF/ERK signalling output whether or 757 
not abnormally high Fgf17 bioavailability was the primary cause. Analogously we interpret 758 
rescue of the Hs6st1-/- precocious astroglial precursor translocation phenotype in Hs6st1-/-759 
;Fgf8neo/neo embryos as evidence that Hs6st1 normally acts to keep FGF/ERK signalling in 760 
check rather than as evidence for a selective genetic interaction between Fgf8 and Hs6st1 761 
(Clegg et al., 2014). Conversely, failure to rescue the Hs2st-/- phenotype in Fgf17-/-;Hs2st-/- 762 
embryos (or using other methods to reduce Fgf17 protein levels or functionality) would not 763 
falsify the hypothesis that increased Fgf17 bioavailability caused the Hs2st-/- phenotype 764 
because there are several alternative explanations. When we employed a similar strategy in a 765 
similar context to rescue the Hs6st1-/- astroglial precursor precocious translocation phenotype 766 
by genetically reducing Fgf8 dosage the rescue was only successful in a minority of isogenic 767 
Hs6st1-/-;Fgf8neo/neo embryos and a likely explanation is that compensatory mechanisms act 768 
when Fgf gene dosage is manipulated (Clegg et al., 2014). Such compensation will generate 769 
false negative results making it unsafe to interpret unrescued Fgf17-/-;Hs2st-/- embryos as 770 
falsifying the hypothesis that the phenotype is underpinned by excess Fgf17 protein. There 771 
are additional technical confounds that could lead to false negatives because a rescue likely 772 
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requires precise restoration of normal Fgf17 protein levels (so no rescue could reflect 773 
technical failure to restore Fgf17 protein levels to normal) and in any case the CC phenotype 774 
of Fgf17-/- embryos has not been thoroughly characterised so Hs2st-/-;Fgf17-/- phenotypes 775 
may well be problematic to interpret (Cholfin and Rubenstein, 2007, 2008). In addition to not 776 
being decisive for or against selectivity we note that demonstrating genetic interaction 777 
between Hs2st and Fgf17 would not provide insight into whether the interaction was 778 
molecularly direct or not, in contrast to biochemical LACE data we present in the current 779 
study.  780 
The closely related ‘Fgf8 subfamily’ members Fgf17 and Fgf8 are both transcribed by 781 
cells in the CSB region yet have different roles in forebrain development with available 782 
evidence, while not ruling out a role for Fgf17, suggesting that Fgf8 is the primary driver of 783 
astroglial precursor translocation required for CC development (Cholfin and Rubenstein, 784 
2007, 2008; Gobius et al., 2016; Moldrich et al., 2010; Toyoda et al., 2011). The independent 785 
suppression of Fgf17 and Fgf8 protein levels by HS modified by Hs2st and Hs6st1 786 
respectively may have facilitated the evolution of this system by providing a mechanism to 787 
tilt the Fgf17:Fgf8 protein balance to give Fgf8 the more dominant role in regulating 788 
astroglial precursor translocation (Chan et al., 2017; Clegg et al., 2014), Current study). In 789 
this sense there are parallels to other negative regulatory strategies, for example micro-RNAs 790 
that function by protecting cells from the expression of particular proteins that would be 791 
detrimental if expressed. 792 
 793 
Figure Legends: 794 
 795 
Figure 1. Hs2st protein is expressed in the cerebral cortex and the septum during CC 796 
formation. (A) Immunohistochemistry for Hs2st at E14.5 (B-D) Higher magnification shows 797 
punctate subcellular Hs2st expression (inset, B) Hs2st protein is expressed at the CSB (B), 798 
the VZ of the cortex (C) and the cortical plate (D). (E) Immunohistochemistry for Hs2st at 799 
E18.5 (F-M) Hs2st protein is expressed in the IG (F), the GW (G), the septum (H), and the 800 
ventral telencephalon (I). Within the cortex Hs2st is expressed at the ventricular zone (J), the 801 
intermediate zone (K), Hs2st is not strongly expressed by the middle layers of the cortex (L), 802 
but is expressed by the deeper layers (M). (N-R) Hs2st antibody specificity. The Hs2st 803 
antibody produces signal in the GW (J,L), which is lost in Hs2st-/- embryos (K,M). Western-804 
blot performed on protein extracted from whole telencephalon using Hs2st antibody reveals 805 
the predicted ~42kDa band in WT extracts, which is lost in Hs2st-/- extracts (N). B-D are 806 
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higher magnification images of boxed regions indicated in A. F-M are higher magnification 807 
images of boxed regions indicated in E. L and M are higher magnification images of boxed 808 
regions in J and K respectively. Insets in B, F, P and Q are higher magnification images of 809 
boxed regions. Scale bars: 500μm in A, 50μm in B-I, L, M; 100μm in J,K. 810 
 811 
Figure 2. Slit2 expression at the CSB of WT and Hs2st-/- embryos at E16.5. (A, C, E) In-situ 812 
hybridisation for Slit2 in WT embryos at 3 rostro-caudal positions labelling the GW and IG. 813 
(B, D, F) In situ hybridisation for Slit2 in Hs2st-/- embryos at equivalent positions to A, C and 814 
E respectively showing an expanded IG. Scale bar: 100μm in all panels. 815 
 816 
Figure 3.  Emx1 and Zic4 lineage contribution at the CSB.  (A) Zic4cre allele combined with a 817 
lox-stop GFP reporter has been used to label cell populations at E18.5. Zic4cre labels cells of 818 
the septum. (B, C, D, E) Zic4cre labels cells ventral to the CSB (dashed line, B,C) including 819 
Sox9 expressing cells (arrowheads, C) but is not expressed by Sox9 expressing cells dorsal to 820 
the CSB (arrows, C). Zic4cre is expressed by IG glial cells (arrowheads, D) but not by 821 
surrounding cells. Zic4cre is expressed by MZ glial cells (arrowheads, E). (F) Schematic of 822 
the Zic4cre expressing cell lineage. (G) Emx1creER allele combined with a lox-stop GFP 823 
reporter has been used to label cell populations at E18.5. Emx1creER labels cells of the cortex. 824 
(H, I, J, K) Emx1creER labels cells dorsal to the CSB (dashed line, H,I) including Sox9 825 
expressing cells (arrowheads, I) but is not expressed by Sox9 expressing cells ventral to the 826 
CSB (arrows, I). Emx1creER is not expressed by IG glial cells (arrows, J). Emx1creER is not 827 
expressed by MZ glial cells (arrows, K). (L) Schematic of the Emx1 expressing cell lineage. 828 
No phenotype was detected in Hs2st+/+ Zic4cre or Hs2st+/+ Emx1creER embryos (n=5 for each 829 
genotype). C, D and E are higher magnification images of the indicated regions in B.  I, J and 830 
K are higher magnification images of the indicated regions in H. Scale bars: 500μm in A,G; 831 
200μm in B and H; 50μm in C-E and I-K. 832 
 833 
Figure 4. HS expression is required within both Emx1 and Zic4 lineage cells for CC 834 
formation. (A-I) Immunofluorescence for L1 (red) at E18.5 labels the CC while GFAP 835 
(green) labels glia. In control embryos the U-shaped CC has formed and is flanked by glia at 836 
the IG and GW (A, D, G). In Ext1fl/fl Emx1creER embryos CC axons do not cross the midline 837 
while glia at the IG and GW appear largely unaffected (B, E, H). In Ext1fl/fl Zic4cre embryos 838 
CC axon do not cross the midline while glia appear depleted at the IG and form abnormal 839 
bundles at the GW (C, F, I). (J-O) FGFR1/ FGF2 ligand and carbohydrate engagement 840 
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(LACE) assay is used to detect the presence of HS. In control embryos LACE signal can be 841 
seen throughout the telencephalon, and is of similar intensity within both the cortex and the 842 
septum (J, M). In Ext1fl/fl Emx1creER embryos LACE signal is significantly reduced within the 843 
cortex (K, N). In Ext1fl/fl Zic4cre embryos LACE signal is significantly reduced within the 844 
septum (L, O). D-I are higher magnification images of the indicated boxed regions in A-C, J-845 
L are higher magnification images of the boxed region in G-I respectively. Scale Bars: 846 
200μm in A-C and G-I; 100μm in D-F and J-L. 847 
 848 
Figure 5. Hs2st expression is required within Emx1 lineage cells but not Zic4 lineage cells 849 
for CC formation. (A-C) Immunofluorescence for L1 and GFAP at E18.5. In control embryos 850 
the U-shaped CC has formed and the IG can be observed above the CC (A). In Hs2stfl/fl 851 
Zic4cre embryos the CC and IG form normally (B). In around half of Hs2stfl/fl;Emx1creER 852 
embryos the CC fails to form, IG glia also extend ventrally (asterisks, C). In the remaining 853 
Hs2stfl/fl;Emx1creER embryos the CC forms normally (C’). (D-I) Immunofluorescence for Sox9 854 
labels progenitor cells at the ventricular zone and mature glia at the IG, GFP labels cells in 855 
which cre is active. (D, G) In control (Hs2st+/+;Emx1creER) embryos IG glia do not express 856 
GFP. (E, H) In Hs2stfl/fl;Zic4cre embryos IG glia do express GFP and adopt their normal 857 
position. (F, I) In Hs2stfl/fl;Emx1creER embryos GFP is expressed by cortical neurons and 858 
axons but not by abnormally positioned IG glia. (J-L) Immunohistochemistry for Hs2st 859 
shows expression of Hs2st in the IG. (J) in control embryos punctate Hs2st staining can be 860 
seen within IG cells. In Hs2stfl/fl Zic4cre embryos Hs2st is not expressed by IG glia (K). In 861 
Hs2stfl/fl;Emx1creER embryos Hs2st is expressed by displaced glial cells (L). Hs2st 862 
immunohistochemistry in J-L was performed on adjacent tissue sections to those in D-I. (M) 863 
Quantification of Sox9 expressing cell number at the IG in control (blue bar, n=4 embryos, 2 864 
Hs2st+/+;Zic4cre+ 2 Hs2st+/+;Emx1creER), affected Hs2stfl/fl;Emx1creER (orange bar, n=4 865 
embryos), and Hs2stfl/fl;Zic4cre (purple bar, n=3 embryos). Sox9+ numbers are significantly 866 
increased compared to control in  Hs2stfl/fl;Emx1creER embryos (* indicates p<0.05 on graph), 867 
(F(2, 7) = 42.16, p = 0.00013, ANOVA), post-hoc t-tests: control vs Hs2stfl/fl;Emx1creER   (t(4) 868 
= -8.08, p = 0.0013, t-test); &  control vs Hs2stfl/fl;Zic4cre (t(5) = 0.92, p = 0.40, t-test). Boxed 869 
regions in G-I are higher magnification images of boxed regions in D-F respectively. Insets in 870 
J, K and L are higher magnification images of boxed region shown on each image. Scale 871 
bars: 200μm in A-F; 100μm 50μm in G-I and J-L.  872 
 873 
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Figure 6: Hs2st is not required by CC axons in order to cross the telencephalic midline. (A, 874 
D) After homotypic transplantation of E17.5 cortical explants from GFP+ control tissue into 875 
the cortex of GFP- control brain slices GFP+ CC axons are able to project across the midline 876 
(arrows, D). (B, E) After transplantation of GFP+ Hs2st-/- cortical explants into GFP- control 877 
brain slices GFP+ CC axons are able to project across the midline (arrows, E). (C, F) After 878 
transplantation of cortical explants from GFP+ control tissue into the cortex of GFP- Hs2st-/- 879 
brain slices GFP+ CC axons are unable to project across the midline and invade the septum. 880 
Arrowheads indicate axons navigating into the septum in all conditions. (G-I) Schematic of 881 
transplant experiments shown in A-C. D-F are higher magnification images of the boxed 882 
region in A-C respectively. Scale bars: 200μm in all panels. 883 
 884 
Figure 7. Hyperactive Fgf signalling causes precocious glia translocation in Hs2st-/- CSB. 885 
(A) Experimental outline of Hs2st-/- phenotypic rescue experiment. Pregnant females were 886 
injected at E14.5 with a BrdU pulse and CSB slices collected after 1 hour and cultured for 887 
48hrs (B-I) WT or Hs2st-/- CSB slices were cultured in the presence of either SU5402 (FGFi) 888 
or DMSO (untreated vehicle control). (B, D, F, H) pErk immunohistochemistry shows that 889 
FGFi treatment reduces Fgf/ERK signalling. (C,E,G,I) Immunofluorescence for BrdU and 890 
Sox9 in WT (C,E) and Hs2st-/- (G,I) slices treated with FGFi (E,I) or untreated (C,G), the 891 
curved dotted line demarcates the basal edge of the VZ, arrows in C,G point to accumulations 892 
of BrdU/Sox9+ cells at the midline (arrow size corresponds to cell number) with higher 893 
magnification insets showing Sox9/BrdU+ (yellow) double labelled cells in IG region. (J) 894 
Quantification of Sox9/BrdU+ double labelled cells in WT or Hs2st-/- CSB slice cultures 895 
treated with FGFi or untreated (n=3 embryos for each condition). For both genotypes FGFi 896 
treatment significantly reduces the number of Sox9/BrdU+ cells that exit the VZ and moved 897 
towards the IG at one or more rostro-caudal position (significant differences due to FGFi 898 
treatment within each genotype indicated on graph as **p<0.05 ***p<0.001). (F(3, 32) = 899 
31.00, p = 0.0000000014, Two-way ANOVA) followed by t-test with Sidak’s correction for 900 
multiple comparisons at each positon along the rostro-caudal axis. WT FGFi vs WT untreated: 901 
position 1 (t(16) = 1.67, p = 0.24, t-test); position 2 (t(16) = 2.37, p = 0.11, t-test); position 3 902 
(t(16) = 2.25, p = 0.15, t-test); & position 4 (t(16) = 2.81, p = 0.050, t-test). Hs2st-/- FGFi vs 903 
Hs2st-/- untreated: position 1 (t(16) = 2.38, p = 0.11, t-test); position 2 (t(16) = 2.83, p = 904 
0.048, t-test); position 3 (t(16) = 3.05, p = 0.030, t-test); & position 4 (t(16) = 4.60, p = 905 
0.0012, t-test). Scale bars: 100μm B-I. 906 
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Figure 8. Expression of Fgf17 during CSB development in WT and Hs2st-/- and Hs6st1-/- 907 
embryos. (A-C) Fgf17 protein and mRNA expression at the E12.5 CSB of WT and Hs2st-/- 908 
embryos. Fgf17 protein is expressed across the CSB in both WT and Hs2st-/- embryos, with 909 
no obvious change in intensity or domain of expression. Fgf17 mRNA expression overlaps 910 
well with the protein expression domain and is similar between WT and Hs2st-/-. (D-F) Fgf17 911 
protein and mRNA expression at the E14.5 CSB of WT and Hs2st-/- embryos. Fgf17 protein is 912 
expressed at low levels at the CSB of WT embryos. In Hs2st-/- embryos, the protein 913 
expression domain expands across the CSB (asterisks in E2). Fgf17 mRNA is unchanged at 914 
the CSB between WT and Hs2st-/- embryos. (G-I) Fgf17 protein and mRNA expression at the 915 
E16.5 CSB of WT and Hs2st-/- embryos. Fgf17 protein is expressed at low levels at the CSB 916 
of WT embryos (H1). In Hs2st-/- embryos, the protein expression domain expands (asterisks, 917 
H2). There is a concurrent increase in Fgf17 mRNA (asterisk, I2). (J-O) Fgf17 mRNA (J, 918 
K1,2,3 L1,2,3) and Fgf17 protein (M, N1,2,3 O1,2,3) expression (red) relative to GFP+ Zic4 lineage 919 
cells (indicated with white arrows) at the GW (K1,2,3, N1,2,3) and IG (L1,2,3, O1,2,3) of WT E14.5 920 
embryos. (P) E14.5 expression of Hs2st by LacZ staining. Hs2st is expressed most highly at 921 
the VZ, with decreasing expression towards the pial surface. (Q-V) Fgf17 protein and mRNA 922 
expression at the E14.5 CSB of WT and Hs6st1-/- embryos. Fgf17 protein is expressed at low 923 
levels at the CSB of WT embryos (Q1,R1). In Hs6st1-/- embryos, the protein expression 924 
domain is similar to WT (Q2,R2). Fgf17 mRNA expression is unchanged between WT and 925 
Hs6st1-/- embryos (S1, S2). (T-V) Fgf17 protein and mRNA expression at the E16.5 CSB of 926 
WT and Hs6st1-/- embryos. Fgf17 protein is expressed at very low levels at the CSB of both 927 
WT (T1, U1) and Hs6st1-/- (T2, U2) embryos. Fgf17 mRNA expression is unchanged between 928 
WT (V1) and Hs6st1-/- (V2) embryos. (W) Quantification of Fgf17 immunofluorescence signal 929 
at CSB in WT (blue bar, n=3 embryos), Hs2st-/- (green bar, n=3 embryos) and Hs6st1-/- 930 
(purple bar, n=3 embryos). Fgf17 protein level is significantly increased compared to WT in 931 
Hs2st-/- embryos (* indicates p<0.05 on graph),  (F(2, 9) = 13.83, p = 0.0018, ANOVA), post-932 
hoc t-tests:  WT vs Hs2st-/-   (t(4) = -4.22, p = 0.014, t-test); & WT vs Hs6st1-/- (t(6) = -0.98, p 933 
= 0.36, t-test). Boxed areas in A,D,G,Q,T shown at higher magnification in B,E,H,R,U 934 
respectively. Scale bars: 200μm in A,D,G,Q,T; 100μm in B,C,E,F,H,I,R,S,U,V,J,M,P; 10μm 935 
in K,L,N,O.  936 
 937 
 938 
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Figure 9. Fgf17-bead experiment. (A) Experimental outline of Fgf17 protein bead 939 
experiment in WT embryos. Pregnant females were injected at E14.5 with a BrdU pulse and 940 
CSB slices collected. One Fgf17 and one BSA bead were added to each side of the midline. 941 
(B) Fgf17 protein and pErk after 2 hours in culture. In both WT and Hs2st-/- CSB slices, Fgf17 942 
and pErk are seen in tissue surrounding the Fgf17 bead. Staining for either is absent around 943 
the BSA bead (demarcated by dotted circle). (C) Immunofluorescence for BrdU and Sox9 944 
was performed on slices after 48 hours in culture, curved dotted lines indicate the basal edge 945 
of the VZ and straight dotted line indicates the midline. D shows a higher power of the 946 
arrowed regions in C. (E) Quantification of Sox9+/BrdU+ double labelled cells in CSB slice 947 
cultures with Fgf17 or BSA bead. The Fgf17 bead significantly increased the number of 948 
Sox9+/BrdU+ cells that exit the VZ and moved towards the IG (significant differences 949 
indicated on graph as **p<0.05 ***p<0.001) at the four caudal-most positions (n=5 950 
embryos). (F(1, 48) = 65.63, p = 0.000000000155, Two-way ANOVA) followed by t-test 951 
with Sidak’s correction for multiple comparisons for Fgf17-bead vs BSA-bead at each 952 
rostral-caudal position: position 1 (t(48) = 1.45, p = 0.63, t-test); position 2 (t(48) = 2.36, p = 953 
0.13, t-test); position 3 (t(48) = 3.65, p = 0.0039, t-test); position 4 (t(48) = 4.47, p = 0.0003, 954 
t-test); position 5 (t(48) = 4.03, p = 0.0012, t-test); & position 6 (t(48) = 3.89, p = 0.0018, t-955 
test). (F) Slit2 expression in slices cultured with Fgf17 and BSA beads. Scale bars: 100μm. 956 
  957 
Figure 10 Model. Hs2st expressed in Emx1 lineage cells catalyses 2-O HS sulphation (2-O 958 
HS) that in turn supresses levels of Fgf17 protein, but not Fgf8 protein, by an unknown 959 
mechanism at the CSB. Zic4 lineage astroglial precursors respond to Fgf8 and Fgf17 protein 960 
by activating FGF/ERK signalling and translocating (black arrows) to the midline. This 961 
generates appropriate positioning of Slit2+ astroglia to guide corpus callosum axons across 962 
the midline. Loss of 2-O HS from the Emx1 lineage selectively de-supresses Fgf17 protein 963 
levels while leaving Fgf8 protein unaffected. This causes hyperactive FGF/ERK signalling 964 
and more Zic4 lineage astroglial precursors translocate than normal with consequent blocking 965 
of corpus callosum axon midline crossing by the ectopic midline Slit2+ astroglia. Zic4 lineage 966 
astroglial precursor cells do not need to express 2-O HS in order to respond to FGF signalling 967 
proteins and translocate to the midline. 968 
 969 
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Figure 11 Ligand and carbohydrate engagement (LACE) assay for FGF:HS interactions. (A-970 
J, O) FGFR1/FGF17 LACE experiments on (A-E) E14.5 and (F-J) E16.5 telencephalic 971 
coronal sections through the CSB. (A,F) WT, (B,G) Hs2st-/-, (C,H) Hs6st1-/- (D,I) WT 972 
sections pretreated with Heparinitase to digest HS, (E,J) WT sections with FGF17 ommitted 973 
from the LACE assay. (O) Quantification of FGF17/FGFR1 LACE signal in WT (blue bar, 974 
n=9 embryos), Hs2st-/- (green bar, n=5 embryos), and Hs6st1-/- (purple bar, n=4 embryos), 975 
showing a significant decrease (* indicates p<0.05 on graph) in Hs2st-/- embryos,(F(2, 15) = 976 
8.62, p = 0.0032, ANOVA), followed by post-hoc t test: WT vs Hs2st-/-   (t(9) = 6.11, p = 977 
0.014, t-test); & WT vs Hs6st1-/- (t(5) = 0.63, p = 0.56, t-test) (K-N, P) FGFR3/FGF8 LACE 978 
experiments on E14.5 telencephalic coronal sections through the CSB. (K) WT, (L) Hs2st-/-, 979 
(M) WT sections pretreated with Heparinitase to digest HS, (N) WT sections with FGF8 980 
ommitted from the LACE assay. (P) Quantification of FGF8/FGFR3 LACE signal in WT 981 
(blue bar, n=3 embryos), Hs2st-/- (green bar, n=3 embryos) shows no significant difference 982 
(t(3) = 0.29, p = 0.76, t-test). Numbers of embryos of each genotype analysed indicated under 983 
bars. (Q) Summary diagram. FGFR1/FGF17/HS complex formation is equally supported by 984 
WT and Hs6st1-/- HS but less so by Hs2st-/- HS while FGFR3/FGF8/HS complex formation is 985 
equally supported by WT and Hs2st-/- HS showing that FGF17:HS physical molecular 986 
interaction is selectively dependent on 2-O HS sulphation. Higher magnification showing the 987 
CSB region boxed in A-N are shown in A’-N’ (note the DAPI channel is not shown in the 988 
higher magnification images to improve visualisation of the LACE signal). Scale bars 989 
200μm.   990 
 991 
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